Mutations in the p53 tumor suppressor gene in tree shrew hepatocellular carcinoma associated with hepatitis B virus infection and intake of aflatoxinB1
Us. Park et al., Mutations in the p53 tumor suppressor gene in tree shrew hepatocellular carcinoma associated with hepatitis B virus infection and intake of aflatoxinB1, GENE, 251(1), 2000, pp. 73-80
Infection with hepadnaviruses and exposure to aflatoxin B1 (AFB1) are consi
dered to be major risk factors in the development of hepatocellular carcino
ma (HCC) in humans. A high rate of p53 mutations at codon 249 has been repo
rted in these tumors. The tree shrew (Tupaia belangeri chinensis) is a usef
ul animal model for the development of HCC after human hepatitis B virus (H
BV) infection or AFB1 treatment. Therefore, it was of particular interest t
o determine whether the p53 gene in tree shrew HCCs associated with HBV inf
ection and/or with exposure to AFB1 is affected in the same manner as in hu
man HCCs. We determined the tree shrew p53 wild-type nucleotide sequences b
y RT-PCR and automatic DNA-sequencing. Tree shrew wild-type p53 sequence sh
owed 91.7 and 93.4% homologies with human p53 nucleotide and amino acids se
quences, respectively, while it showed 77.2 and 73.7% homologies in mice. O
ne HCC and normal liver tissue from AFB1 treated and one HCC from AFB1- and
HBV-treated tree shrew showed no change in p53 sequences, while three HCCs
from AFB1- and HBV-treated tree shrews showed point mutations in p53 seque
nces. One HCC showed point mutations at codon 275, which is on the DNA-bind
ing domain of p53 gene, which might be a cause of gain-of-function during t
he development of HCC. As a result, our finding indicates that tree shrews
exposed to AFB1 and/or HBV had neither codon 249 mutations nor significant
levels of other mutations in the p53 gene, as is the case with humans. (C)
2000 Elsevier Science B.V. All rights reserved.